1998
DOI: 10.1007/s001040050427
|View full text |Cite
|
Sign up to set email alerts
|

Multimodale Therapie des Coloncarcinoms

Abstract: A large variety of immunological and cytotoxic adjuvant treatment concepts and application routes have been observed to be effective in colon cancer by randomized trials during the past three decades. Presently adjuvant 5-fluorouracil based chemotherapy is favoured for patients with lymph node metastases (UICC stage III), since this treatment was associated with a 5-10% increase in 5-year survival. Uncertainty persists regarding the optimal use of adjuvant treatment, since marked differences in prognosis have … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
1
0
3

Year Published

1998
1998
2003
2003

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 30 publications
0
1
0
3
Order By: Relevance
“…Abrasion arthroplasty was one of the chondrostimulative methods most widely used against cartilage damage [12] but its application met wide criticism because of the unsuccessful results reported by several authors [4, 11, 12, 23].…”
Section: Discussionmentioning
confidence: 99%
“…Abrasion arthroplasty was one of the chondrostimulative methods most widely used against cartilage damage [12] but its application met wide criticism because of the unsuccessful results reported by several authors [4, 11, 12, 23].…”
Section: Discussionmentioning
confidence: 99%
“…Bereits 1982 forderte Sugarbaker: ¹Important aspects of the techniques for large-bowel surgery need to be investigated by prospective controlled clinical trialsª [66] [8,42]. Dies bedeutet, dass 95 % der Patienten keinen Nutzen von einer adjuvanten Behandlung haben [19].…”
Section: Kontrollierte Studiendaten Zum Operationstaktischen Und -Tecunclassified
“…Auch bei Nachweis von isolierten Tumorzellen in Lymphknoten oder Knochenmark wird eine adjuvante Therapie im Stadium I oder II nicht empfohlen [5]. Für das Stadium UICC I und II gibt es keine adjuvante Therapieempfehlung.…”
Section: Adjuvante Therapieunclassified
“…Es wurden in der Vergangenheit eine ganze Reihe von prognostischen Stagingsystemen entwickelt, doch wird heute weltweit die ᭤ TNM-Klassifikation (Tabelle 3) der UICC (Union international contre le cancre;5. Aufl.…”
unclassified